Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes

Molecular Pharmacology

Volumn 73, Issue 6, 2008, Pages 1622-1631

  Pinet, Caroline ^a,d   Algalarrondo, Vincent ^b   Sablayrolles, Sylvie ^c   Le Grand, Bruno ^c   Pignier, Christophe ^c   Cussac, Didier ^c   Perez, Michel ^c   Hatem, Stephane N ^b   Coulombe, Alain ^b  

^a CNRS   (France)

^b INSERM   (France)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^d UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOENOL LACTONE; CALCIUM; LACTONE; PHOSPHOLIPASE A2; PROTEINASE ACTIVATED RECEPTOR 1; SODIUM CHANNEL; TETRODOTOXIN; THROMBIN;

ACTION POTENTIAL; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; GUINEA PIG; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROELECTRODE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SODIUM CURRENT; SODIUM TRANSPORT; WHOLE CELL;

ACTION POTENTIALS; AGED; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RECEPTOR, PAR-1; SODIUM CHANNELS; THROMBIN;

EID: 44249103991     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.043182     Document Type: Article

References (38)

1. Ahn H and Chackalamannil S (2001) Nonpeptide thrombin receptors antagonists. Drugs Future 26:1065-1085.
2. 2+ channels activated by chlorpromazine and free radicals in membrane of human atrial myocytes. J Mol Cell Cardiol 30:2623-2636.
3. + exchanger activity: signalling and significance. Cardiovasc Res 57:942-952.
4. Barry GD, Le GT, and Fairlie DP (2006) Agonists and antagonists of protease activated receptors (PARs). Curr Med Chem 13:243-265.
5. Belardinelli L, Shryock JC, and Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92(Suppl 4):iv6 -iv14.
6. Brette F and Orchard CH (2006) No apparent requirement for neuronal sodium channels in excitation-contraction coupling in rat ventricular myocytes. Circ Res 98:667-674.
7. Chackalamannil S and Xia Y (2006) Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents. Expert Opin Ther Pat 16:493-505.
8. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264.
9. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, et al. (2000) Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157:1849-1862.
10. Fedida D, Orth PM, Hesketh JC, and Ezrin AM (2006) The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers. J Cardiovasc Electrophysiol 17 (Suppl 1):S71-S78.
11. Glembotski CC, Irons CE, Krown KA, Murray SF, Sprenkle AB, and Sei CA (1993) Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. J Biol Chem 268:20646-20652.
12. Goldstein JA, Butterfield MC, Ohnishi Y, Shelton TJ, and Corr PB (1994) Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia. Circulation 90:139-147.
13. Haigney MC, Lakatta EG, Stern MD, and Silverman HS (1994) Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90:391-399.
14. + channel mutation leading to loss of function and non-progressive cardiac conduction defects. J Mol Cell Cardiol 35:549-557.
15. Jacobsen AN, Du XJ, Lambert KA, Dart AM, and Woodcock EA (1996) Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation 93:23-26.
16. Jiang T, Kuznetsov V, Pak E, Zhang H, Robinson RB, and Steinberg SF (1996) Thrombin receptor actions in neonatal rat ventricular myocytes. Circ Res 78:553-563.
17. Kiyosue T and Arita M (1989) Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ Res 64:389-397.
18. Lavi S, Lavi R, McConnell JP, Lerman LO, and Lerman A (2007) Lipoprotein-associated phospholipase a(2): review of its role as a marker and a potential participant in coronary endothelial dysfunction. Mol Diagn Ther 11:219-226.
19. Makielski JC, Ye B, Valdivia CR, Pagel MD, Pu J, Tester DJ, and Ackerman MJ (2003) A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 93:821-828.
20. Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M, and Undrovinas AI (1998) Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98:2545-2552.
21. + current in human ventricular cardiomyocytes. Cardiovasc Res 69:116-127.
22. Noble D and Noble PJ (2006) Late sodium current in the pathophysiology of cardiovascular disease: consequence of sodium-calcium overload. Heart 92:iv1-iv5.
23. Park TH, McHowat J, Wolf RA, and Corr PB (1994) Increased lysophosphatidylcholine content induced by thrombin receptor stimulation in adult rabbit cardiac ventricular myocytes. Cardiovasc Res 28:1263-1268.
24. Pinet C, Le Grand B, John GW, and Coulombe A (2002) Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading. Circulation 106:2098-2103.
25. Sabri A, Muske G, Zhang H, Pak E, Darrow A, Andrade-Gordon P, and Steinberg SF (2000) Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res 86:1054-1061.
26. Sabri A, Short J, Guo J, and Steinberg SF (2002) Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91:532-539.
27. + current during cardiac ischemia and hypoxia. J Cardiovasc Electrophysiol 17 (Suppl 1):S96-S103.
28. Sakmann BF, Spindler AJ, Bryant SM, Linz KW, and Noble D (2000) Distribution of a persistent sodium current across the ventricular wall in guinea pigs. Circ Res 87:910-914.
29. Steinberg SF (2005) The cardiovascular actions of protease-activated receptors. Mol Pharmacol 67:2-11.
30. Steinberg SF, Robinson RB, Lieberman HB, Stern DM, and Rosen MR (1991) Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res 68:1216-1229.
31. Strande JL, Hsu A, Su J, Fu X, Gross GJ, and Baker JE (2007) SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res Cardiol 102:350-358.
32. Undrovinas AI, Fleidervish IA, and Makielski JC (1992) Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 71:1231-1241.
33. + channel in normal and failing human myocardium. J Mol Cell Cardiol 34:1477-1489.
34. Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, and Makielski JC (2005) Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 38:475-483.
35. Valdivia CR, Nagatomo T, and Makielski JC (2002) Late Na currents affected by alpha subunit isoform and beta1 subunit co-expression in HEK293 cells. J Mol Cell Cardiol 34:1029-1039.
36. Woodcock EA, Matkovich SJ, and Binah O (1998) Ins(1,4,5)P3 and cardiac dysfunction. Cardiovasc Res 40:251-256.
37. Wu L, Shryock JC, Song Y, and Belardinelli L (2006) An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 316:718-726.
38. + during myocardial ischemia. Am J Physiol 268:H1740-H1748.